Herceptin become most prescribed biologic with KRW 100 billion

Published: 2018-02-26 16:26:00
Updated: 2018-02-26 16:29:30

‘Herceptin,’ a breast cancer therapy, has become the only biologic with more than KRW 100 billion prescriptions a year.

CoreZetta(CEO Hong-Ki Lee), a health care big data company, analyzed data about 22 biologics turned in to the Health Insurance Review & Assessment Service, and the analysis sho...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.